PDT Partners’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

PDT Partners’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-23,883	Closed	-$405K	–	1509
2014 Q4	$405K	Sell	23,883 -89,517	-79%	-$1.26M	0.04%	484
2014 Q3	$1.35M	Buy	113,400 +70,012	+161%	+$478K	0.03%	534
2014 Q2	$245K	Buy	+43,388	New	+$200K	0.01%	1260
2014 Q1	–	Sell	-65,600	Closed	-$220K	–	1425
2013 Q4	$220K	Buy	65,600 +13,100	+25%	+$54.1K	0.03%	576
2013 Q3	$223K	Buy	+52,500	New	+$249K	0.01%	1362

PDT Partners's AVNR Position: Q1 2015 in Review

PDT Partners sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 23,883 shares — an estimated $405K sold.

PDT Partners first reported a position in AVNR in Q3 2013 and held it in 5 quarters. The position peaked at $1.35M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

PDT Partners reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
PDT Partners sold 23,883 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $405K.
PDT Partners first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q3 2013 and held it in 5 quarters.
PDT Partners's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.35M in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on PDT Partners's 13F filing for Q1 2015, filed 15 May 2015.